about
Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cellsPalmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in ratsNeuromodulators for pain management in rheumatoid arthritisStructure of malonamidase E2 reveals a novel Ser-cisSer-Lys catalytic triad in a new serine hydrolase fold that is prevalent in natureInhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptorsSupersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseTreatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.Is lipid signaling through cannabinoid 2 receptors part of a protective system?CB2 receptor-mediated migration of immune cells: it can go either wayCB2 receptors in the brain: role in central immune functionThe endocannabinoid system as an emerging target of pharmacotherapyThe cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurinNovel cannabinoid receptorsEpidermal anti-Inflammatory properties of 5,11,14 20:3: effects on mouse ear edema, PGE2 levels in cultured keratinocytes, and PPAR activation.Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretionAlternative RNA splicing: contribution to pain and potential therapeutic strategyPalmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndromeAdvances in the discovery of N-acylethanolamine acid amidase inhibitorsOf mice and (wo)men: factors influencing successful implantation including endocannabinoidsA lipid gate for the peripheral control of painA fatty gut feelingAntineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityEvidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative painBinding and Inactivation Mechanism of a Humanized Fatty Acid Amide Hydrolase by α-Ketoheterocycle Inhibitors Revealed from Cocrystal StructuresA Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide HydrolasePalmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacyModulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamideA pilot trial of low-dose naltrexone in primary progressive multiple sclerosisAlkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsTargeting cannabinoid agonists for inflammatory and neuropathic painIncreased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout miceHU-308: a specific agonist for CB(2), a peripheral cannabinoid receptorAntiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the ratPalmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cellsEffects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamideThe endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airwaysCannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammationInhibitory effect of palmitoylethanolamide on gastrointestinal motility in miceCharacterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamideEffects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen
P2860
Q21144343-76F49E10-7758-4865-B590-0D538EE17A69Q21203937-93DDA17B-DEBA-4025-9A6E-62408FC78A76Q24203885-C01F3533-3C3D-49CD-8FC4-C603BF0EB01BQ24536561-85A21049-D73B-4784-9414-42591A3DB36BQ24554356-9B47EC8E-C3CC-4DC8-B3AB-B19C13907EFEQ24555807-2FE4A4BC-0C0B-48ED-A878-682B10287F9AQ24630453-72AA24F8-4B2E-4923-986F-5C2CB99703E6Q24633122-9594F313-A775-4871-AEC6-CC9D4061ABDAQ24643591-2DA95D14-BC62-41BD-8E0D-A783D284EF32Q24643895-A18BB448-9DD6-4F43-83EC-405257DADDD4Q24648473-DC008097-AF78-47E9-BDC6-A2BB27B1BAA0Q24676808-2D4C6F15-9C2F-4C25-B6D0-D675BA599742Q24681482-554FBB25-B9E9-49F0-9EDD-379433763157Q24793905-AB10CD41-3A63-4430-BE30-7C5154F68E95Q24800293-2BC9C2EF-AB47-430A-A1C6-E00CB1A9472AQ26744085-6CA2C5BA-EF47-41E3-AE07-088098629D07Q26775847-5B06F2F6-54D6-4CD3-ACB9-7CA27A84FAB8Q26866274-26153420-8B8C-42D9-8A46-476597045462Q26992063-133FB5C1-3DB5-4B18-BDEB-2FED2C79434BQ26995053-16E3A1BD-2F58-482E-82F2-CEA6DCA63B52Q26999343-30500E8A-0336-475E-9D00-1577FB704E04Q27305830-DB853710-5E3E-4856-993A-4CE50E399B39Q27325738-48F20D94-A8D1-47EE-AA28-9A6D7E1C8F1FQ27657268-69EB951D-1BD6-4901-A66D-E3B9CA66F883Q27675504-56ABBA22-F22F-4223-BCAF-AF995C8102E5Q28066248-989EA196-0BDE-4301-A05A-CF54D0C00996Q28248981-A9FBB9E1-5229-4E85-8ADA-B227C769C963Q28291875-6F2926F4-8C62-4161-84F9-4A3BF746FB01Q28302804-9EF53BF2-269E-4EAE-9A6D-5DC294E1E5D2Q28307619-0A93260B-A4B2-4264-98B2-8B5C13309798Q28343324-71647848-C05C-40EC-ABFC-18D011DE6874Q28343769-A56F1E67-5B04-4BD7-9695-0328FAF287F1Q28344879-C9DD5712-D38A-4A8D-8B91-1ED1C47381E4Q28345246-95635F44-E2EC-4A9E-9BDB-DE77C77FF060Q28345762-C6278FE7-081B-4BB1-BC0A-E6842CDFB2B2Q28354238-8FEA4090-10AF-467F-9970-40F84AD44807Q28361058-51FAECCE-43F6-475A-B62B-C7B7D53ED75DQ28362696-0CFED9E1-E1D5-449B-B359-ED258C6425F9Q28363051-2DEB9FB4-2ECD-470A-8097-F6BE8CA68F55Q28366569-39E700CF-F639-4F48-9A80-E9EDAB7302F4
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Control of pain initiation by endogenous cannabinoids.
@ast
Control of pain initiation by endogenous cannabinoids.
@en
Control of pain initiation by endogenous cannabinoids.
@nl
type
label
Control of pain initiation by endogenous cannabinoids.
@ast
Control of pain initiation by endogenous cannabinoids.
@en
Control of pain initiation by endogenous cannabinoids.
@nl
prefLabel
Control of pain initiation by endogenous cannabinoids.
@ast
Control of pain initiation by endogenous cannabinoids.
@en
Control of pain initiation by endogenous cannabinoids.
@nl
P356
P1433
P1476
Control of pain initiation by endogenous cannabinoids
@en
P2093
P2888
P304
P356
10.1038/28393
P407
P577
1998-07-01T00:00:00Z
P6179
1020600705